In our study, it was particularly interesting to see that many tau regulated proteins and tau interactors were altered in epilepsy despite no change in total tau levels in proteomic studies, suggesting that the downstream tau effects can occur regardless of bulk tissue expression levels. The gene discussed is MAPT; the disease is epilepsy.